SWP
NVAX icon

Stratos Wealth Partners’s Novavax NVAX Stock Holding History

Stratos Wealth Partners’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,823
Closed -$208K – 1266
2022
Q1 		$208K Buy
2,823
+155
+6% +$13.8K ﹤0.01% 1157
2021
Q4 		$382K Buy
2,668
+381
+17% +$65.5K 0.01% 918
2021
Q3 		$474K Buy
2,287
+491
+27% +$108K 0.01% 768
2021
Q2 		$381K Buy
+1,796
New +$329K 0.01% 868
2021
Q1 		– Sell
-2,210
Closed -$246K – 1153
2020
Q4 		$246K Buy
+2,210
New +$235K 0.01% 923
2020
Q3 		– Sell
-4,395
Closed -$366K – 1051
2020
Q2 		$366K Buy
+4,395
New +$168K 0.01% 705
2018
Q4 		– Sell
-125
Closed -$5K – 1935
2018
Q3 		$5K Buy
+125
New +$3.52K ﹤0.01% 2460
2018
Q2 		– Sell
-125
Closed -$5K – 2037
2018
Q1 		$5K Hold
125
– – ﹤0.01% 2611
2017
Q4 		$3K Buy
+125
New +$3.05K ﹤0.01% 2527

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Stratos Wealth Partners's NVAX Position: Q2 2022 in Review

Stratos Wealth Partners sold out of Novavax (NVAX) in Q2 2022, closing a stake of 2,823 shares — an estimated $208K sold.

Stratos Wealth Partners first reported a position in NVAX in Q4 2017 and held it in 9 quarters. The position peaked at $474K in Q3 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Stratos Wealth Partners reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Stratos Wealth Partners sold 2,823 Novavax shares in Q2 2022, an estimated $208K.
  • Stratos Wealth Partners first reported a position in Novavax in Q4 2017 and held it in 9 quarters.
  • Stratos Wealth Partners's Novavax position peaked at $474K in Q3 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Stratos Wealth Partners's 13F filing for Q2 2022, filed 22 Jul 2022.